patritumab
Daiichi Sankyo,Amgen
['mbc', 'her3-dxd', 'daiichi']
don't miss oral abstract on early results from phase 2 study of her3-dxd in pts with mbc from at 11:30am #asco23 
Creating Aha! Moments In Healthcare
IDEOlogy Health is leading the change in how HCPs stay up-to-date.